Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Chinese Patent Office
UBS
Moodys
Accenture
QuintilesIMS
Johnson and Johnson
Fish and Richardson
AstraZeneca

Generated: February 22, 2018

DrugPatentWatch Database Preview

DOLOPHINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Dolophine Hydrochloride, and when can generic versions of Dolophine Hydrochloride launch?

Dolophine Hydrochloride is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in DOLOPHINE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
Drug patent expirations by year for DOLOPHINE HYDROCHLORIDE
Pharmacology for DOLOPHINE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for DOLOPHINE HYDROCHLORIDE

US Patents and Regulatory Information for DOLOPHINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DOLOPHINE HYDROCHLORIDE methadone hydrochloride SYRUP;ORAL 006134-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int DOLOPHINE HYDROCHLORIDE methadone hydrochloride TABLET;ORAL 006134-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int DOLOPHINE HYDROCHLORIDE methadone hydrochloride TABLET;ORAL 006134-010 Approved Prior to Jan 1, 1982 AA RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Federal Trade Commission
Baxter
US Army
US Department of Justice
AstraZeneca
Chubb
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot